Preclinical studies on the anticancer activity of the somatostatin analogue octreotide (SMS 201-995)

This publication has 15 references indexed in Scilit:

• Somatostatin and Analogues in the Treatment of Cancer
  Annals of Surgery, 1991
• Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane
  Journal of Surgical Research, 1991
• Physiological role of somatostatin on growth hormone regulation in humans
  Metabolism, 1990
• Interplay of somatostatin and growth hormone-releasing hormone in genesis of episodic growth hormone secretion
  Metabolism, 1990
• Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and sandostatin
  British Journal of Cancer, 1989
• Direct Inhibitory Effects of a Somatostatin Analog, SMS 201-995, on AR4-2J Cell Proliferation via Pertussis Toxin-Sensitive Guanosine Triphosphate-Binding Protein-Independent Mechanism*
  Endocrinology, 1989
• Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995
  The American Journal of Surgery, 1988
• Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary
  Neuroscience, 1985
• Clinical Applications of Somatostatin Analogs
  Published by Springer Nature ,1985
• SOMATOSTATIN INHIBITS RAPID CENTROSOMAL SEPARATION AND CELL PROLIFERATION INDUCED BY EPIDERMAL GROWTH FACTOR.
  Endocrinology, 1982